EIF3A and cancer: Although we have clearly shown that eIF3a is regulated by Wnt/β-catenin signaling pathway in cell-based studies and that APC mutation up-regulates eIF3a expression in the APCmm/+ animal model, it remains to be determined if the increased eIF3a expression in human colon cancers is due to APC mutation in these cancers.